aspirin has been researched along with oligonucleotides in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aberle, LG; Alexander, JH; Becker, RC; Chan, MY; Chronos, N; Cohen, MG; Dyke, CK; Gilchrist, IC; Harrington, RA; Kleiman, NS; Lin, M; Melloni, C; Myles, SK; Rusconi, CP; Steinhubl, SR; Tonkens, RM; Vorchheimer, DA; Walder, J | 1 |
Boffa, MB; Koschinsky, ML | 1 |
Harangi, M; Paragh, G; Zsíros, N | 1 |
2 review(s) available for aspirin and oligonucleotides
Article | Year |
---|---|
Screening for and management of elevated Lp(a).
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Aspirin; Atherosclerosis; Biomarkers; Canada; Female; Humans; Lipoprotein(a); Male; Mass Screening; Oligonucleotides; Oxazolidinones; Predictive Value of Tests; Risk Factors | 2013 |
[Clinical significance of and treatment options for increased lipoprotein(a)].
Topics: Aspirin; Biomarkers; Blood Component Removal; Cardiovascular Diseases; Carrier Proteins; Cholesterol Ester Transfer Proteins; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Hypolipidemic Agents; Lipoprotein(a); Niacin; Oligonucleotides; Proprotein Convertase 9; Proprotein Convertases; Risk Factors; Serine Endopeptidases | 2014 |
1 trial(s) available for aspirin and oligonucleotides
Article | Year |
---|---|
Phase 1b randomized study of antidote-controlled modulation of factor IXa activity in patients with stable coronary artery disease.
Topics: Aged; Antidotes; Aptamers, Nucleotide; Aspirin; Clopidogrel; Coronary Artery Disease; Double-Blind Method; Drug Combinations; Factor IXa; Female; Humans; Male; Middle Aged; Oligonucleotides; Ticlopidine; Treatment Outcome | 2008 |